SCHEMBL10128098

SCHEMBL10128098

c1ccc2cc(-c3ccc4oc5c(-c6ccc(-c7nnc8c9ccccc9ccn78)cc6)cc(-c6ccc7ccccc7c6)cc5c4c3)ccc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.34
ALDH1A1 P00352 6/20 0.34
KDM4E B2RXH2 4/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
POLB P06746 2/20 0.34
ESR1 P03372 1/20 0.34
HPGD P15428 3/20 0.33
HSD17B10 Q99714 3/20 0.33
CASP1 P29466 2/20 0.33
CASP7 P55210 2/20 0.33
TSHR P16473 2/20 0.33
ALOX15 P16050 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128111 0.99 MAPT (0.33) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10128099 0.93 PIM1 (0.36) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10128083 0.93 PIM1 (0.36) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10128108 0.91 PIM1 (0.35) MAPTALDH1A1KDM4EKMT2APOLB
SCHEMBL10128112 0.91 ENPP3 (0.34) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10128115 0.91 MAPT (0.39) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10128104 0.88 KDM4E (0.35) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10128101 0.88 ENPP3 (0.34) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10128113 0.88 ALDH1A1 (0.34) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10128121 0.87 MAPT (0.35) MAPTALDH1A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 MAPT 1271/4885ALDH1A1 1032/4885KDM4E 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.